| |
|
|
|
Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory
August 4 -10, 2009
Drug addiction is the most costly neuropsychiatric disorder faced by our nation. Acute and repeated exposure to drugs produces neuroadaption and long-term memory of the experience, but the cellular and molecular processes involved are only partially understood. The primary objective of the proposed workshop is to provide an intense dialogue of the fundamentals, state-of-the-art advances and major gaps in the cell and molecular biology of drug addiction.Targeted to new or experienced investigators, the workshop will combine formal presentations and informal discussions to convey the merits and excitement of cellular and molecular approaches to drug addiction research. With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop comprehensive models of neuroadaptative processes fundamental to addiction, withdrawal, craving, and relapse to drug use and to brain function, in general. A range of disciplines and topics will be represented, including noninvasive brain imaging to identify drug targets and adaptive processes; neuroadaptative processes at the molecular and cellular level, neural networks and their modulation, the relevance of genotype to susceptibility and drug response; tolerance and adaptation at the cellular level and approaches to exploiting the daunting volume generated by neuroinformatics. This workshop will provide an integrated view of current and novel research on neuroadaptive responses to addiction, foster discussion on collaboration and integration, provide critical information needed to construct a model of addiction as a disease and novel molecular targets for biological treatments. Beyond the plane of scientific endeavor, the information is vital for formulating public policy and for enlightening the public on the neurobiological consequences of drug use and addiction. The workshop is designed to generate interest in this level of analysis, open conduits for collaborations and present novel routes to investigating the neurobiology of addictive drugs.
|
|
|
|
|
|
|
|
Organized by:
|
|
Christopher Evans, University of California, Los Angeles Mark Von Zastrow, University of California, San Francisco |
|
|
Invited Speakers:
|
|
2009 Speakers to be announced Speakers in the last course included:
Huda Akil, University of Michigan
George Augustine, Duke University Medical Center
Wade Berrettini, University of Pennsylvania
Lakshmi Devi, Mount Sinai School of Medicine
Robert Edwards, University of California, San Francisco
David Goldman, NIAAA/LNG
Martin Iguchi, University of California - Los Angeles
Peter Kalivas, Medical University of South Carolina
Brigitte Kieffer, Institut de Genetique et de Biologie Moleculaire et Cellulaire
George Koob, The Scripps Research Institute
Mary Jeanne Kreek, Rockefeller University
Angus Nairn, Yale University School of Medicine
Eric Nestler, UT Southwestern at Dallas
Marina Picciotto, Yale University
John Pintar, UMDNJ
Jonathan Pollock, National Institute on Drug Abuse/NIH/DHHS
Wolfgang Sadee, Ohio State University
John Williams, Oregon Health & Science Institute
Robert Williams, UT Memphis
Renping Zhou, Rutgers UniversityCollege of Pharmacy
Jon-Kar Zubieta, University of Michigan
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
Application Deadline March 15
|
|
|
|
|
|
|
|
Registration:
|
|
Online Application Information
|
|
|
E-mail:
|
|
meetings@cshl.edu
|
|
|
|
|
|
|
|
|